ABSTRACT

Boletim com o objetivo de conhecer o perfil das internações por Hipertensão arterial (HA) no estado de Goiás no ano de 2023, de acordo com a sua classificação e complicações associadas a partir dos códigos de Classificação Internacional de Doenças-10ª revisão (CID-10) e seu impacto no total de internações por causas sensíveis à atenção primária. Os dados sobre as internações foram extraídos de Internações Hospitalares (SIH) e das estimativas populacionais elaboradas pelo Ministério da Saúde. Foram feitas buscas de internações pelo grupo de CID-10 relacionada às doenças hipertensivas

Bulletin with the aim of knowing the profile of hospitalizations for Hypertension (AH) in the state of Goi's in the year 2023, according to its classification and associated complications based on the International Classification of Diseases-10 revision (ICD) codes -10) and its impact on total hospitalizations for causes sensitive to primary care. Data on hospitalizations were extracted from Hospital Admissions (SIH) and population estimates prepared by the Ministry of Health. Searches for hospitalizations were carried out using the ICD-10 group related to hypertensive diseases

ABSTRACT

Introducción: un nuevo tipo de coronavirus que se nombró SARSCoV-2, responsable de la enfermedad por COVID-19, tuvo esparcimiento rápido en el mundo, por alta transmisión que resultó en pandemia. Se registraron 2'397,216 casos confirmados, con 162,956 defunciones en el mundo, de acuerdo con la Organización Mundial de la Salud (OMS), en abril de 2020. Sin embargo, la hipertensión afecta a 40% de adultos, lo que significa que alrededor de 250 millones de personas padecen de presión alta. La OMS, de acuerdo con sus reportes, refiere que la hipertensión es el factor de riesgo número uno de muerte. Uno de cada cuatro mexicanos padece hipertensión arterial. Objetivos: establecer la incidencia de la hipertensión arterial sistémica posterior a padecer COVID-19 en pacientes de la Unidad de Medicina Familiar (UMF) No. 48. Material y métodos: es un estudio transversal, observacional y descriptivo, conformado por 3,238 pacientes con diagnóstico de COVID-19 positivo, de ambos sexos, con edades entre 18 y 70 años. Por medio de la fórmula para poblaciones infinitas se obtiene una muestra de 348 pacientes. Se realizó revisión de expedientes en el Sistema de Información de Medicina Familiar, versión 6.2, para obtención de la información correspondiente. Resultados: 27 pacientes diagnosticados con hipertensión arterial posterior al diagnóstico de COVID-19, 52% del sexo masculino y 48% del femenino, con media de edad de 39 años, 74% correspondió a enfermedad leve por COVID-19 y 26% a enfermedad moderada. Se documenta mediana de ocho días por periodo de infección por COVID-19. En el círculo femenino el promedio de la aparición de hipertensión arterial fue de 13 meses y en el masculino la media de desarrollo de hipertensión arterial posterior a COVID-19 fue de seis meses (AU)

Introduction: a new type of coronavirus that was named SARSCoV-2, responsible for the COVID-19 disease, with rapid spread in the world, due to high transmission that resulted in pandemic. There were 2'397,216 confirmed cases, with 162,956 deaths in the world, according to the WHO in April 2020. However, hypertension affects 40% of adults and means that around 250 million people suffer from high blood pressure. The WHO, according to its reports, refers that hypertension is the number one risk factor for death. One in four Mexicans suffers from high blood pressure. Objectives: to establish the incidence of systemic arterial hypertension after suffering from COVID-19 in patients of the UMF No. 48. Material and methods: it is a cross-sectional, observational and descriptive study, consisting of 3,238 patients with a positive COVID-19 diagnosis of both sexes, aged 18-70 years. Through the formula for infinite populations a sample of 348 patients is obtained. Will proceed with review of files in the Family Medicine Information System, version 6.2, to obtain the corresponding information. Results: 27 patients diagnosed with hypertension after the diagnosis of COVID-19, 52% of the male sex and 48% of the female sex, with a mean age of 39 years; 74% corresponds to a mild illness by COVID-19 and 26% to moderate disease. A median of 8 days per period of infection by COVID-19 is documented. In the female circle, the average onset of hypertension was 13 months and as for the male sex, the mean development of hypertension after COVID-19 was six months (AU)

ABSTRACT

Systemic Arterial Hypertension is a multifactorial clinical condition associated with severe outcomes such as stroke and death. One of the main modifiable risk factor for hypertension is an unhealthy diet, often characterized by the consumption of ultraprocessed foods such as sweetened beverages. We aimed to investigate the relationship between the consumption of sweetened beverages, both sugar-sweetened and artificially sweetened, and the prevalence of hypertension in adults. A cross-sectional, household, population-based study with 1,162 adults from two Brazilian cities were carried out. The consumption of food groups and sweetened beverages was obtained by food frequency questionnaire and other data were self-reported. Weight, height, and waist circumference were measured. The association between sweetened beverages consumption and hypertension was analyzed using Poisson regression models, expressed as Prevalence Ratio. The prevalence of hypertension was 16.7%, with no significant difference between genders. The prevalence of consumption of sweetened beverages was 70.3% in men and 54.6% in women, being significantly higher in men. Women who consumed sugar-sweetened and artificially sweetened beverages 6 to 7 days per week had 92% higher prevalence of hypertension compared to those who did not consume or consumed at a lower frequency. Furthermore, women who consumed artificially sweetened beverages at least 1 time per week had 3.36 times higher prevalence of hypertension. The habitual consumption of sweetened beverages may be an important risk factor for hypertension, especially the consumption of diet beverages, which are often marketed as healthier than sugar-sweetened beverages.

La Hipertensión Arterial Sistémica es una condición clínica multifactorial asociada a resultados graves como el ictus y la muerte. Uno de los principales factores de riesgo modificables de la hipertensión es una dieta poco saludable, a menudo caracterizada por el consumo de alimentos ultraprocesados como las bebidas endulzadas. Nuestro objetivo fue investigar la relación entre el consumo de bebidas endulzadas, tanto azucaradas como edulcoradas artificialmente, y la prevalencia de hipertensión en adultos. Se realizó un estudio transversal, domiciliario y poblacional con 1,162 adultos de dos ciudades brasileñas. El consumo de grupos de alimentos y bebidas endulzadas se obtuvo mediante cuestionario de frecuencia de alimentos y los demás datos fueron autoinformados. Se midieron el peso, la talla y el perímetro de la cintura. La asociación entre el consumo de bebidas endulzadas y la hipertensión se analizó mediante modelos de regresión de Poisson, expresados como Ratio de Prevalencia. La prevalencia de hipertensión fue del 16,7%, sin diferencias significativas entre géneros. La prevalencia de consumo de bebidas endulzadas fue del 70,3% en los hombres y del 54,6% en las mujeres, siendo significativamente mayor en los hombres. Las mujeres que consumían bebidas azucaradas y edulcoradas artificialmente entre 6 y 7 días a la semana tenían 92% mayor prevalencia de hipertensión que las que no consumían o consumían con una frecuencia menor. Además, las mujeres que consumían bebidas edulcoradas al menos 1 vez por semana tenían una prevalencia de hipertensión 3,36 veces mayor. Así pues, el consumo habitual de bebidas endulzadas puede ser un importante factor de riesgo de hipertensión, especialmente el consumo de bebidas dietéticas, que a menudo se comercializan como más saludables que las bebidas azucaradas.

ABSTRACT

Introducción: Las enfermedades crónicas repercuten en gran medida en la calidad de vida de los pacientes, ya sea por sus características inherentes o por las complicaciones derivadas que ocasionan emergencias recurrentes. Objetivo: Pronosticar los días de hospitalización hasta el desenlace de pacientes con enfermedad crónica ingresados en un hospital público peruano. Métodos: Se realizó una investigación descriptiva, retrospectiva y transversal, entre julio y agosto del 2022, con 488 pacientes con enfermedad crónica ingresados en el Hospital Regional Docente de Cajamarca. Los datos demográficos de ingreso y el tipo de diagnóstico de los pacientes fueron proporcionados por la oficina de estadística del hospital. El análisis univariado se realizó con distribuciones absolutas y relativas, junto a sus intervalos de confianza al 95 por ciento y la relación pronóstica con Log Rank (Mantel-Cox) - ji al cuadrado, análisis de supervivencia de Kaplan-Meier (p < 0,05) y tablas de mortalidad. Resultados: El 53,1 por ciento de pacientes fueron mujeres, con 67,1 años de edad promedio, ingresaron al hospital por el servicio de emergencia (66,0 por ciento) y la enfermedad crónica fue la causa principal (79,1 por ciento). El promedio de hospitalización fue de 67,5 días, con mayor número en la hipertensión arterial (63 días), las diferencias numéricas en el tiempo de hospitalización según enfermedad crónica no se reflejan a nivel estadístico (p = 0,130). Las defunciones ocurrieron dentro del primer mes de hospitalización. Conclusión: Los días de hospitalización hasta el desenlace no son independientes de la enfermedad crónica de los pacientes, pues en ambos casos pueden ocurrir defunciones si sus características clínicas son irrecuperables(AU)

Introduction: Chronic diseases greatly impact the quality of life of patients, either due to their inherent characteristics or due to the derived complications that cause recurrent emergencies. Objective: To predict the days of hospitalization until the outcome of patients with chronic disease admitted to a Peruvian public hospital. Methods: A descriptive, retrospective and cross-sectional investigation was carried out from July to August 2022, with 488 patients with chronic disease admitted to Cajamarca Regional Teaching Hospital. Admission demographic data and type of patient diagnosis were provided by the hospital statistics office. The univariate analysis was performed with absolute and relative distributions, along with their 95percent confidence intervals and the prognostic relationship with Log Rank (Mantel-Cox) - chi square, Kaplan-Meier survival analysis (p < 0.05) and mortality tables. Results: 53.1percent of patients were women, with average age of 67.1 years, who were admitted to the hospital through the Emergency Service (66.0percent) and chronic disease was the main cause (79.1percent). The average hospitalization time was 67.5 days, with greater number in high blood pressure (63 days). The numerical differences in hospitalization time, according to chronic disease, are not reflected at a statistical level (p = 0.130). Deaths occurred within the first month of hospitalization. Conclusion: The days of hospitalization until the outcome are not independent of the patients' chronic illness, since in both cases deaths can occur if their clinical characteristics are irrecoverable(AU)

ABSTRACT

Introducción: La hipertensión arterial no controlada es un problema de salud en los servicios del primer nivel de atención, es frecuente su asociación en los pacientes diagnosticados con COVID-19, en cuanto a complicaciones y a un aumento de la mortalidad. La hipertensión no controlada supone además un reto para los servicios de salud de forma permanente y ante esta pandemia. Objetivo: Exponer algunos problemas que pueden encontrarse en la atención a pacientes hipertensos, relacionados con un inadecuado manejo y control de la enfermedad y que pudieran contribuir a una mala evolución de la COVID-19. Métodos: Se realizó una revisión narrativa desde la búsqueda en las bases de datos Biomed Central, Wiley Online Library, Medline, Scielo Regional y Scielo Cuba, utilizando las palabras claves: hipertensión arterial, hipertensión no controlada, dispensarización, servicios de salud, primer nivel de atención y COVID-19. Fueron revisados 91 artículos, de los cuales se eligieron los estudios más significativos con relación a las deficiencias en el manejo y control de la hipertensión arterial y aquellos que expusieron relaciones entre hipertensión no controlada y mala evolución de la COVID-19. Conclusiones: La hipertensión no controlada es un problema de salud identificado en los servicios de salud del primer nivel de atención y es la comorbilidad más prevalente asociada con la COVID-19, lo cual tiene un impacto desfavorable en la salud de la población(AU)

Introduction: Uncontrolled arterial hypertension is a health problem in services at the first level of healthcare. It is frequently associated with complications and increased mortality in patients diagnosed with COVID-19. Uncontrolled hypertension is also a challenge for healthcare services on a permanent basis and in the face of the COVID-19 pandemic. Objective: To present some problems that may be encountered in the care of hypertensive patients, related to inadequate management and control of the disease and that could contribute to a poor evolution of COVID-19. Methods: A narrative review was carried out by searching in the databases Biomed Central, Wiley Online Library, Medline, SciELO Regional and SciELO Cuba, using the keywords hipertensión arterial [arterial hypertension], hipertensión no controlada [uncontrolled hypertension], dispensarización [dispensarization], servicios de salud [healthcare services], primer nivel de atención [first level of healthcare] and COVID-19. Ninety-one articles were reviewed, from which the most significant studies were chosen in relation to deficiencies in the management and control of arterial hypertension, as well as those that exposed relationships between uncontrolled hypertension and poor evolution of COVID-19. Conclusions: Uncontrolled hypertension is a health problem identified in the services at the first level of healthcare and the most prevalent comorbidity associated with COVID-19, which has an unfavorable impact on population health(AU)

ABSTRACT

OBJETIVO: Realizar una revisión sistemática y metaanálisis que resuma el riesgo de hipoacusia de personas con diagnóstico de síndrome o enfermedades metabólicas versus aquellas sin síndrome metabólico. MATERIAL Y MÉTODOS: Siguiendo las recomendaciones PRISMA para revisión sistemática y metaanálisis, se realizaron búsquedas en 3 indexadores (PubMed, Web of Science y SciELO). Se incluyeron sólo estudios transversales que reportan asociaciones de hipoacusia con obesidad, Hipertensión; Diabetes, Dislipidemia, Colesterol, síndrome metabólico e Hiperglicemia. Las odds ratios (OR) con sus intervalos de confianza (IC) del 95% de los estudios se agruparon en un modelo de efectos aleatorios por el método de Mantel Haenszel. Con Rev Manager 5.1, se evaluó la heterogeneidad OR mediante las estadísticas I2 y Q. RESULTADOS: 28 estudios observacionales fueron incluidos en el análisis cuantitativo. Las OR para hipoacusia prevalente fue de 1.27 (95% IC 1.07, 1.51) en obesidad, 1.97 (95% IC 1.51, 2.57) en diabetes, 1.53 (95% IC 1.31, 1.79) en hipertensión y 4.22 (95% IC 1.74, 10.20) para síndrome metabólico. Conclusiones: Los hallazgos sugieren que tanto el síndrome metabólico como algunas enfermedades como obesidad, diabetes e hipertensión podrían asociarse con el riesgo de hipoacusia, pudiendo el control de estas enfermedades atenuar este riesgo.

INTRODUCTION: Various studies have linked lifestyle and metabolic diseases to hearing loss. Research on metabolic syndrome has reported a higher prevalence of hearing loss in individuals with it than those without it. OBJECTIVES: To conduct a systematic review and meta-analysis summarizing the risk of hearing loss in people diagnosed with metabolic syndrome or diseases versus those without metabolic syndrome. METHODS. Following the PRISMA recommendations for systematic review and meta-analysis, searches were conducted in PubMed, Web of Science, and SciELO. Only cross-sectional studies associate hearing loss with obesity, hypertension, Diabetes, Dyslipidemia, Cholesterol, metabolic syndrome, and Hyperglycemia. The odds ratios (OR) with their 95% confidence intervals (CI) of the studies were pooled in a random effects model using the Mantel-Haenszel method. Using Rev Manager 5.1, OR heterogeneity was assessed using the I2 and Q statistics. Results. Twenty-eight observational studies were included in the quantitative analysis. The OR for prevalent hearing loss was 1.27 (95% CI 1.07, 1.51) in obesity, 1.97 (95% CI 1.51, 2.57) in diabetes, 1.53 (95% CI 1.31, 1.79) in hypertension, and 4.22 (95% CI 1.74, 10.20) for metabolic syndrome. CONCLUSIONS. The findings suggest that both metabolic syndrome and some diseases, such as obesity, diabetes, and hypertension, could be associated with the risk of hearing loss, and control of these diseases could reduce this risk.

ABSTRACT

Introducción: El cáncer de páncreas constituye un problema de salud debido al diagnóstico tardío, su agresividad biológica y la ausencia de un tratamiento sistémico efectivo. Objetivo: Caracterizar clínica, epidemiológica, histológica y anatómicamente a pacientes con cáncer de páncreas. Métodos: Se realizó un estudio descriptivo de casos clínicos, en pacientes con cáncer de páncreas que acudieron al Hospital Oncológico Conrado Benítez; de Santiago de Cuba, en el período comprendido diciembre 2017 hasta diciembre 2018. El universo estuvo conformado por el total de los pacientes de ambos sexos, cuya cifra ascendió a 19 que cumplieron con los criterios de inclusión. Resultados: No existió predominio significativo según el sexo, prevaleció el grupo de edades entre 61-70 años en un 31,6 por ciento, el 84,2 por ciento de los pacientes presentó como factor de riesgo la dieta rica en grasas y pobre en verduras y el tabaquismo, en el 63,2 por ciento coexistió la hipertensión arterial, la pérdida de peso fue el signo que sobresalió en el 79,0 por ciento. El 47,4 por ciento se les diagnosticó adenocarcinoma poco diferenciado, siendo la localización más frecuente de los tumores (31,6 por ciento) la cabeza del páncreas. Conclusiones: El cáncer de páncreas es una enfermedad maligna que se relacionada con la edad y sus síntomas se manifiestan tardíamente, se asocia con la presencia de factores de riesgo por lo que es necesario identificarlos precozmente, modificarlos y/o atenuarlos(AU)

Introduction: Pancreatic cancer constitutes a health problem due to late diagnosis, its biological aggressiveness and the absence of effective systemic treatment. Objective: To clinically, epidemiologically, histologically and anatomically characterize patients with pancreatic cancer. Methods: A descriptive study of clinical cases was carried out in patients with pancreatic cancer who attended the Conrado Benítez; Oncological Hospital of Santiago de Cuba, in the period from December 2017 to December 2018. The universe was made up of the total number of patients of both genders, which amounted to 19 meeting the inclusion criteria. Results: There was no significant predominance according to gender, the age group between 61-70 years prevailed in 31.6 percent, 84.2 percent of patients presented as risk factor the diet rich in fat and poor in vegetables and smoking, in 63.2 percent coexisted arterial hypertension, weight loss was the sign that stood out in 79.0 percent. The 47.4 percent were diagnosed with poorly differentiated adenocarcinoma, being the pancreatic head the most frequent location of the tumors (31.6 percent). Conclusions: Pancreatic cancer is an age-related malignant disease and its symptoms manifest late that is associated with the presence of risk factors, so it is necessary to identify them early, modify and/or attenuate them(AU)

ABSTRACT

BACKGROUND: The largest growth in cases of COVID-19 worldwide during 2020 was in the Americas, and Chile was one of the most affected countries. AIM: To describe, characterize, and evaluate the use of drugs as treatment for COVID-19 in hospitalized patients in Chile during the first wave of the pandemic. METHODS: We performed a multicenter, observational study that included 442 patients with confirmed SARS-CoV-2 infection admitted in Chilean hospitals between March 21 and September 22, 2020. The analysis included demographics, comorbidities, specific drug therapy, and outcomes over a 28-day follow-up period. RESULTS: The median age of patients was 68 years (IQR 55-73), and 38.9% were women. The most common comorbidities were hypertension (57.7%) and diabetes (36.9%). Fifty-seven (12.9%) patients died. Hypertension (HR 2.99; CI 95% 1.43-6.26) and age ≥; 65 (2.14; CI 95% 1.10- 4.17) were the main predictors of mortality. Primary drugs were azithromycin (58.8%) and corticosteroids (51.1%). In this sample, azithromycin was a protective factor regarding mortality (HR 0.53; CI 95% 0.31-0.90), increasing clinical improvement and avoiding progression. CONCLUSIONS: The patterns of use of drugs to treat COVID-19 in Chile during the first wave of the pandemic were very dynamic and followed the international, evidence-based guidelines. The low mortality rate indicates that the clinical management of hospitalized patients was adequate.

ANTECEDENTES: Durante 2020, el mayor incremento de casos de COVID-19 se observó en el continente americano, donde Chile fue uno de los países más afectados. Objetivos: Describir, caracterizar y evaluar el uso de fármacos indicados para tratar el COVID-19 en pacientes hospitalizados en Chile durante la primera ola de pandemia. PACIENTES Y MÉTODOS: Un estudio multicéntrico observacional incorporó a 442 pacientes con infección confirmada por SARS- CoV-2 admitidos en hospitales chilenos entre el 21 de marzo y el 22 de septiembre de 2020. Se analizaron variables demográficas, comorbilidades, terapia farmacológica específica y desenlaces clínicos para un período de seguimiento de 28 días. Resultados: La mediana de la edad fue de 68 años (RIC 55-73), y un 38,9% fueron mujeres. Las comorbilidades más comunes fueron hipertensión (57,7%) y diabetes (36,9%). Cincuenta y siete (12,9%) de los pacientes murieron. Los principales predictores de mortalidad fueron la hipertensión (HR 2,99; IC 95% 1,43-6,26) y la edad ≥ 65 años (2,14; IC 95% 1,10- 4,17). Los fármacos más utilizados fueron azitromicina (58,8%) y corticosteroides (51,1%). En esta muestra, la azitromicina fue un factor de protección respecto a la mortalidad (HR 0,53; IC 95% 0,31-0,90), incrementando igualmente la mejoría y evitando la progresión. CONCLUSIONES: Los patrones de uso de fármacos para tatar COVID-19 en Chile durante la primera ola de pandemia fueron muy dinámicos y siguieron las directrices internacionales basadas en la evidencia. La baja mortalidad sugiere que el manejo de los pacientes hospitalizados fue adecuado.

ABSTRACT

BACKGROUND@#The prevalence of hypertension is high among Chinese adults, thus, identifying non-hypertensive individuals at high risk for intervention will help to improve the efficiency of primary prevention strategies.@*METHODS@#The cross-sectional data on 9699 participants aged 20 to 80 years were collected from the China National Health Survey in Gansu and Hebei provinces in 2016 to 2017, and they were nonrandomly split into the training set and validation set based on location. Multivariable logistic regression analysis was performed to develop the diagnostic prediction model, which was presented as a nomogram and a website with risk classification. Predictive performances of the model were evaluated using discrimination and calibration, and were further compared with a previously published model. Decision curve analysis was used to calculate the standardized net benefit for assessing the clinical usefulness of the model.@*RESULTS@#The Lasso regression analysis identified the significant predictors of hypertension in the training set, and a diagnostic model was developed using logistic regression. A nomogram with risk classification was constructed to visualize the model, and a website ( https://chris-yu.shinyapps.io/hypertension_risk_prediction/ ) was developed to calculate the exact probabilities of hypertension. The model showed good discrimination and calibration, with the C-index of 0.789 (95% confidence interval [CI]: 0.768, 0.810) through internal validation and 0.829 (95% CI: 0.816, 0.842) through external validation. Decision curve analysis demonstrated that the model was clinically useful. The model had a higher area under receiver operating characteristic curves in training and validation sets compared with a previously published diagnostic model based on Northern China population.@*CONCLUSION@#This study developed and validated a diagnostic model for hypertension prediction in Gansu Province. A nomogram and a website were developed to make the model conveniently used to facilitate the individualized prediction of hypertension in the general population of Han and Yugur.

ABSTRACT

OBJECTIVE@#To explore the characteristics of comorbidities in patients with osteoporosis(OP) and factors associated health-related quality of life, so as to provide decision-making reference for improving the ability of disease co-prevention and co-treatment and the patient's life-cycle quality of life.@*METHODS@#From November 2017 to July 2018, clinical information and biological samples from residents in 10 communities in Chaoyang District and Fengtai Distric of Beijing were collected, and bone density testing was conducted. Based on the Charlson comorbidity index (CCI), the comorbidity of the population was quantified, and grouped according to factors such as gender, age, and the differences between the groups were explored. Combined with the clinical information of patients, the difference characteristics of comorbidity and non-comorbidity population were analyzed. Pearson/Spearman correlation analysis and binary Logistic regression analysis were used to explore the factors affecting the health-related quality of life in patients with OP.@*RESULTS@#Among the 521 OP patients, 121 patients had no comorbidities, and there were 153, 106, 65, and 30 patients with one, two, three, and four comorbidities, respectively, 46 patients with 5 or more kinds of comorbidites. Hypertension was the most common comorbidity in OP patients, accounting for 21.60%;followed by hyperlipidemia, accounting for 13.51%. The most common combination of the two diseases was hypertension plus hyperlipidemia (64 cases, 12.28%). Through the analysis of differences between age groups, it was found that the older patients, showed higher the CCI, and the difference between groups was statistically significant(Z=1.93, P=0.05). There were significant differences in the total EQ-5D score and the dimensions of anxiety and depression between patients with comorbidities (CCI≠0) and non-comorbidities (CCI=0) (Z=-2.67, P=0.01;Z=-2.44, P=0.02). Correlation analysis found that CCI, history of fracture, history of falls, hip bone mineral density T value and parathyroid hormone were all related to the health-related quality of life in OP patients (P<0.05). Binary Logistic regression analysis suggested that the right hip bone mineral density T value (P=0.02), CCI (P=0.01), fracture history (P=0.03) and fall history (P=0.01) were the risk factors that affect the health-related quality of life in OP patients.@*CONCLUSION@#The burden of comorbidities among middle-aged and elderly OP populations in Beijing is relatively heavy, and the health management of such populations should be further strengthened, specifically the combination of multiple comorbidities should be given high priority. Comorbid factors are of great importance for the diagnosis and treatment strategy of OP patients, which could further improve the quality of life.

ABSTRACT

Objective: To investigate the distribution of blood pressure and analyze the associated factors of blood pressure of the elderly with type 2 diabetes in Jiangsu Province. Methods: The elderly over 60 years old participants with type 2 diabetes in the communities of Huai'an City and Changshu City, Jiangsu Province were selected in this study. They were divided into two groups: taking antihypertensive drugs and not taking antihypertensive drugs. The demographic characteristics, such as age and sex, and relevant factors were collected by questionnaire. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured by physical examination. The percentile of SBP and DBP in each age group of men and women were described. The kernel density estimation curve was used to show the blood pressure distribution. The trend of blood pressure with age was fitted by locally weighted regression. The logistic regression model was used to analyze relevant factors of blood pressure. Results: A total of 12 949 participants were included in this study, including 7 775 patients in the antihypertensive drug group and 5 174 patients in the group without antihypertensive drugs. The SBP of participants was concentrated at 140-160 mmHg, and their DBP was concentrated at 75-85 mmHg. There were significant differences in the distribution of blood pressure among the subgroups of body mass index (BMI) and rural areas whether taking antihypertensive drugs and not. For participants aged under 80 years old, the SBP showed an increasing trend with age and the DBP showed a decreasing trend with age. Age, BMI ≥24 kg/m2, fasting blood glucose ≥7.0 mmol/L, living in rural areas and no smoking were influencing factors of the elevated SBP; BMI ≥24 kg/m2, male, living in rural areas, no smoking, drinking alcohol and not receiving drug hypoglycemic treatment were influencing factors of the elevated DBP. Conclusion: The SBP of older diabetic adults in Jiangsu Province is at a high level, and the distribution of blood pressure is significantly different between men and women in taking antihypertensive drugs group. The SBP presents a rising trend and the DBP is decreasing at the age of 60-80 years. The blood pressure level of this population are mainly affected by age, BMI, urban and rural areas, smoking.

ABSTRACT

Objective: To investigate the association of mixed exposure to greenness and nitrogen dioxide(NO2) and hypertension among the older adults aged 65 years and over in China. Methods: The study subjects were from the Chinese Longitudinal Healthy Longevity Survey from 2017 to 2018. A total of 15 423 older adults aged 65 years and over meeting the criteria were finally included in the study. A questionnaire survey was used to collect information on demographic characteristics, lifestyle habits and self-reported prevalence of hypertension. Blood pressure values were obtained through physical examination. The level of normalized difference vegetation index(NDVI) was measured by the Medium-resolution Imaging Spectral Radiator(MODIS) of the National Aeronautics and Space Administration(NASA). The concentration of NO2 was from China's surface air pollutant data set. Meteorological data was from NASA MERRA-2. The exposure to NDVI and NO2 for each study subject was calculated based on the area within a 1 km radius around their residence. The association between mixed exposure of NDVI and NO2 as well as their interaction and hypertension in older adults was analyzed by using the multivariate logistic regression model. The restrictive cubic spline(RCS) function was used to explore the exposure-response relationship between greenness and NO2 and the risk of hypertension in study subjects. Results: The mean age of 15 423 older adults were (85.6±11.6). Women accounted for 56.3%(8 685/15 423) and 55.6%(8 578/15 423) lived in urban areas. The mean time of residence was (60.9±28.5) years. 59.8% of participants were with hypertension. The mean NDVI level was 0.41±0.13, and the mean NO2 concentration was (32.18±10.36) μg/cm3. The results of multivariate logistic regression analysis showed that NDVI was inversely and linearly associated with the hypertension in older adults, with the OR(95%CI) value of 0.959(0.928-0.992). Compared with the T1 group of NDVI, the risk of hypertension was lower in the T3 group, with the OR(95%CI) value of 0.852(0.769-0.944), and the trend test was statistically significant(P<0.05). Compared with the T1 group of NO2, the risk of hypertension was higher in the T2 and T3 groups, with OR(95%CI) values of 1.160(1.055-1.275) and 1.244(1.111-1.393), and the trend test was statistically significant (P<0.05). The result of the RCS showed that NDVI was inversely and linearly associated with hypertension in older adults. NO2 was nonlinearly associated with hypertension in older adults. The interaction analysis showed that NDVI and NO2 had a negative multiplicative interaction on the risk of hypertension, with OR(95%CI) value of 0.995(0.992-0.997). Conclusion: Exposure to greenness and NO2 are associated with hypertension in older adults.

ABSTRACT

From January 2019 to December 2021, overweight and obese children who visited in health outpatient Center of Hunan Children's Hospital were studied to explore and analyze the rate, related factors and patterns of multimorbidity of overweight and obesity-related diseases in children in Hunan Province. Univariate and multivariate logistic regression models were used to analyze the multimorbidity-related factors of overweight and obesity-related diseases in children. Association rules (apriori algorithm) were used to explore the multimorbidity patterns of overweight and obesity-related diseases in children. A total of 725 overweight and obese children were included in this study. The multimorbidity rate of overweight and obesity-related diseases in children was 46.07% (334/725). Age, waist circumference, the frequency of food consumption such as hamburgers and fries and adding meals before bedtime were multimorbidity-related factors of overweight and obesity-related diseases in children. The multimorbidity associated with nonalcoholic fatty liver disease (NAFLD) was relatively common. The patterns with the top three support degrees were "NAFLD+dyslipidemia","NAFLD+hypertension" and "NAFLD+hyperuricemia". The patterns with the top three confidence and elevation degrees were "Hypertension+dyslipidemia => NAFLD","Hyperuricemia => NAFLD" and "NAFLD+hypertension => dyslipidemia".

ABSTRACT

We aimed to investigate the relationship of dietary zinc intake with new-onset hypertension among Chinese adults. A total of 12,177 participants who were free of hypertension at baseline from the China Health and Nutrition Survey were included. Dietary intake was assessed by three consecutive 24-h dietary recalls combined with a household food inventory. Participants with systolic blood pressure ≽ 140 mmHg or diastolic blood pressure ≽ 90 mmHg or diagnosed by a physician or under antihypertensive treatment during the follow-up were defined as having new-onset hypertension. During a median follow-up duration of 6.1 years, 4269 participants developed new-onset hypertension. Overall, the association between dietary zinc intake and new-onset hypertension followed a J-shape (P for non-linearity < 0.001). The risk of new-onset hypertension significantly decreased with the increment of dietary zinc intake (per mg/day: hazard ratio (HR) 0.93; 95% confidence interval (CI) 0.88-0.98) in participants with zinc intake < 10.9 mg/day, and increased with the increment of zinc intake (per mg/day: HR 1.14; 95% CI 1.11-1.16) in participants with zinc intake ≽ 10.9 mg/day. In conclusion, there was a J-shaped association between dietary zinc intake and new-onset hypertension in general Chinese adults, with an inflection point at about 10.9 mg/day.

ABSTRACT

BACKGROUND@#Hypertensive heart disease (HHD) poses a public health challenge, but data on its burden and trends among older adults are scarce. This study aimed to identify trends in the burden of HHD among older adults between 1990 and 2019 at the global, regional, and national levels.@*METHODS@#Using the Global Burden of Diseases study 2019 data, we assessed HHD prevalence, death, and disability-adjusted life-year (DALY) rates for individuals aged 60-89 years at the global, regional, and national levels and estimated their average annual percentage changes (AAPCs) between 1990 and 2019 using joinpoint regression analysis.@*RESULTS@#In 2019, there were 14.35 million HHD prevalent cases, 0.85 million deaths, and 14.56 million DALYs in older adults. Between 1990 and 2019, the prevalence of HHD increased globally {AAPC, 0.38 (95% confidence interval [CI], 0.36, 0.41)} with decreases observed in mortality (AAPC, -0.83 [95% CI, -0.99, -0.66]) and the DALY rate (AAPC, -1.03 [95% CI, -1.19, -0.87]). This overall global trend pattern was essentially maintained for sex, age group, and sociodemographic index (SDI) quintile except for non-significant changes in the prevalence of HHD in those aged 70-74 years and in the middle SDI quintile. Notably, males had a higher HHD prevalence rate. However, HHD-related mortality and the DALY rate were higher in females. The middle SDI quintile experienced the largest decreases in mortality and the DALY rate, with a non-significant decline in prevalence between 1990 and 2019. There were significant discrepancies in the HHD burden and its trends across regions and countries.@*CONCLUSIONS@#In the past three decades, there has been an overall increasing trend in the prevalence of HHD among older adults worldwide despite decreasing trends in mortality and the DALY rate. Better management of hypertension, and prevention and control of HHD are needed in older adults.

ABSTRACT

OBJECTIVE@#To investigate the associated factors of endogenous erythropoietin (EPO) and its association with 10-year risks of atherosclerotic cardiovascular disease in a Chinese community-based general population.@*METHODS@#The participants of this study were from an atherosclerosis cohort survey which was established by the Department of Cardiology, Peking University First Hospital in 2011. The cohort survey was performed in the Gucheng and Pingguoyuan communities of Shijingshan district in Beijing, China. The inclusion criteria of this study were: (1) endogenous EPO was measured; (2) health questionnaire data and other clinical data were complete; (3) participatants who had cardiovascular or cerebrovascular diseases (defined as self-reported coronary heart disease, stroke or transient ischemic attack) or anemia or estimated glomerular filtration rate (eGFR) < 60 mL/(min·1.73 m2) at baseline were excluded. Multivariate linear regression model was used to examine the associated factors of endogenous EPO. The participants were grouped into low (< 5%), moderate (5%-10%) and high risk (≥10%) groups, based on predicted 10-year cardiovascular disease risk using the prediction for atherosclerotic cardiovascular disease risk in China (China-PAR) equations.@*RESULTS@#A total of 4 013 participants were included. Mean age of them was (55.9±8.2) years, 62.2% (n=2 496) of them were female, and 46.3% (n=1 859), 70.9% (n=2 845), 21.9% (n=879) had hypertension, dyslipidemia and diabetes, individually. The average body mass index was (26.1±3.3) kg/m2. The median of EPO level was 12.8 (9.3-17.4) IU/L and 25.1% (n=998) were at high 10-years risk of cardiovascular disease. Hemoglobin (β=-0.05, 95%CI: -0.07 to -0.04) and eGFR ≥90 mL/(min·1.73 m2) (β=-0.05, 95%CI: -0.07 to -0.04) were associated with lower in transformed EPO levels while hypertension (β=0.08, 95%CI: 0.05 to 0.12) and obesity (β=0.14, 95%CI: 0.09 to 0.18) were associated with higher in transformed EPO levels in multivariate linear regression analyses. Ten-year cardiovascular disease risks were positively associated with in transformed EPO levels (β=0.07, 95%CI: 0.05 to 0.09). The participants at moderate and high cardiovascular disease risks had significant higher EPO levels than the low risk group (all P < 0.05).@*CONCLUSION@#In community-based Beijing populations, endogenous EPO was associated with hemoglobin, renal function, obesity and hypertension. Individuals at high 10-years cardiovascular disease risks have higher endogenous EPO levels. Endogenous EPO may be a potential risk marker of cardiovascular disease.

ABSTRACT

Objective: To describe the prevalence of alcohol consumption and the burden of hemorrhagic stroke and hypertensive heart disease attributed to alcohol consumption in adults aged ≥20 years in 31 provinces in China from 2005 to 2018. Methods: Data from several national representative surveys was used to estimate provincial alcohol exposure level of adults aged ≥20 years from 2005 to 2018 by using kriging interpolation and locally weighted regression methods. Global disease burden research method and data, and China's death cause surveillance data were used to calculate the population attributable fraction (PAF) of hemorrhagic stroke and hypertensive heart disease and the deaths due to alcohol consumption in men and women aged ≥20 years in 31 provinces in China. China census data of 2010 were used to calculate the attributable standardized mortality rate. Results: In 2005 and 2018, the prevalence of alcohol consumption was 58.7% (95%CI: 57.8%-59.5%) and 58.4% (95%CI: 57.6%-59.3%), respectively, in men and 17.0% (95%CI: 16.6%-17.4%) and 18.7% (95%CI:18.1%-19.3%), respectively, in women. The daily alcohol intake was 24.6 (95%CI: 23.8-25.3) g and 27.7 (95%CI: 26.8-28.7) g, respectively, in men and 6.3 (95%CI: 6.0-6.5) g and 5.3 (95%CI: 5.0-5.6) g, respectively, in women. Alcohol exposure level was higher in the provinces in central and eastern China than in western provinces. The lowest exposure level was found in northwestern provinces. From 2005 to 2018, the PAF of hemorrhagic stroke death due to alcohol consumption increased from 5.5% to 6.8%, the attributable deaths increased from 50 200 to 59 100, while the PAF of hypertensive heart disease death due to alcohol consumption increased from 7.0% to 7.7%, the attributable deaths increased from 15 200 to 29 300. The PAF of hypertensive heart disease and hemorrhagic stroke was higher in men than in women, and in central and eastern provinces than in western provinces. In 2018, the standardized mortality rates of hemorrhagic stroke and hypertensive heart disease attributed to alcohol consumption were 4.58/100 000 and 2.11/100 000, respectively. Conclusions: The prevalence of alcohol consumption in men and daily alcohol intake of drinkers were relatively high in China, especially in eastern provinces. Alcohol exposure level was lower in women than in men. Regional measures should be taken to reduce the alcohol intakes in men and current drinkers in order to reduce the health problems caused by alcohol consumption.

ABSTRACT

A conformidade entre as fontes de dados sobre diabetes mellitus (DM) e hipertensão arterial (HA) é fundamental para medidas de vigilância. Neste aspecto, pretende Avaliar se há uniformidade entre os dados de prevalência de DM e HA no Estado de Goiás a partir de duas diferentes fontes de acesso a esses dados. Casuística e métodos: Comparação entre os dados do Levantamento de Hipertensão e Diabetes do estado de Goiás 2021 (LHD) e do banco de dados da Estratégia e-SUS Atenção Básica (e-SUS AB) com relação ao número de indivíduos cadastrados na rede de atenção primária à saúde com os diagnósticos de DM e HA. Resultados: Em Goiás, a diferença entre o número absoluto de indivíduos com diagnóstico de DM e HA pelo LHD e pelo e-SUS AB foi de 46,56% e de 27%, respectivamente (p <0,001). A diferença entre os dados foi maior que 50% para o diagnóstico de DM em 104 municípios e para HA em 94 municípios. Discussão: As divergências encontradas podem estar relacionadas a fatores como a qualidade dos dados fornecidos pela população, duplicidade de registros, problemas técnicos relacionados à internet e ao software e dificuldades na integração entre os sistemas de informação. Demonstra-se a necessidade de padronização de registros e uniformização dos dados para o fortalecimento de ações de vigilância. Concluiu que há inconsistências entre os dados sobre o número de indivíduos cadastrados com os diagnósticos de DM e HA a partir do LHD e e-SUS AB em grande parte dos municípios do Estado de Goiás

Introduction: Conformity between data sources on diabetes mellitus (DM) and hypertension (H) is critical for surveillance measures. Objective: To assess whether there is uniformity between data on the prevalence of DM and H in the State of Goiás, based on two different sources of access to these data. Material and methods: A comparison was made between the data from the 2021 Hypertension and Diabetes Survey of the State of Goiás (LHD) and the data from the e-SUS Primary Care Strategy (e-SUS AB) database about the number of people who had hypertension or diabetes. RESULTS: In Goiás, the difference between the absolute number of individuals diagnosed with DM and H according to data from the LHD and e-SUS AB was 46.56% and 27%, respectively (p <0.001). The difference between the data was greater than 50% for the diagnosis of DM in 104 municipalities and for H in 94 municipalities. Discussion: The differences found may be related to the quality of personal data provided by the population, duplicate records, obstacles in using the software or the internet, difficulties in integrating information systems. The findings demonstrate the necessity of establishing standardized records for data related to these diseases in order to strengthen surveillance actions. Conclusion: There are inconsistencies between the data on the number of individuals registered as having DM and H from the LHD and e-SUS AB in most municipalities in the State of Goiás

ABSTRACT

Resumo Introdução O monitoramento da hipertensão arterial sistêmica (HAS) é realizado no Brasil, fundamentado no autorrelato, por meio do sistema VIGITEL. Tendo em vista lacunas acerca desse agravo em populações de trabalhadores, estas devem ser alvo da ação ampliada para o seu diagnóstico epidemiológico. Objetivo Testar a validade de critério do autorrelato de HAS, comparando-o com medidas aferidas de pressão arterial (PA). Método Realizou-se estudo de corte transversal com amostra aleatória do universo de 1.561 trabalhadores de um serviço judiciário na Bahia. Calcularam-se sensibilidade, especificidade, valores preditivos e razões de probabilidade para o autorrelato de HAS, comparando-os com a aferição direta da PA, medida de referência. O diagnóstico de HAS foi a média de duas aferições com PA sistólica ≥ 140 mmHg, e/ou PA diastólica ≥ 90 mmHg, e/ou uso regular de anti-hipertensivos. Resultados Em amostra de 391 trabalhadores, verificou-se sensibilidade de 66,4% (57,1-74,6%), especificidade de 87,9% (83,2-91,4%), valor preditivo positivo de 70,5% (61,1-78,6%), valor preditivo negativo de 85,7% (80,9-89,4%), razões de probabilidade positiva e negativa de 5,5 (3,88-7,72) e de 0,4 (0,30-0,49), respectivamente. Conclusão Este estudo evidenciou o autorrelato como medida válida para o diagnóstico epidemiológico da HAS entre trabalhadores, recomendando seu uso. No entanto, esta validade depende do diagnóstico prévio do agravo.

Abstract Background Monitoring of hypertension, based on self-report, has been performed in Brazil through VIGITEL. In view of the gaps about this problem in worker populations, these should be the targets of the expanded action of epidemiological diagnosis of hypertension. Objective To test the validity of hypertension self-report in comparison to blood pressure (BP) measurements. Method A cross-sectional study was conducted on a random sample of 1561 workers from a Judicial Service in Bahia. Sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios were calculated for the hypertension self-report in comparison with direct BP measurement (reference). Hypertensive cases presented the mean of two BP measurements, with systolic BP ≥ 140 mmHg, and/or diastolic BP ≥ 90 mmHg and/or regular use of antihypertensive drugs. Results In a sample of 391 workers, there was a sensitivity of 66.4% (57.1-74.6%), a specificity of 87.9% (83.2-91.4%), a positive predictive value of 70.5% (61.1- 78.6%), a negative predictive value of 85.7% (80.9-89.4%), a positive and negative likelihood ratio of 5.5 (3.88-7.72) and 0.4 (0.30-0.49) respectively. Conclusion This study showed self-report as a valid measure to implement the epidemiological diagnosis of hypertension among workers, recommending its use. However, its validity depends on the previous diagnosis.

ABSTRACT

ABSTRACT Objective: To analyze the association of anthropometric indicators of adiposity in older people, according to sex, with hypertension; to compare the scores of these variables between participants with and without hypertension; and to identify among them those with better predictive ability for screening the outcome. Methods: Epidemiological, population-based, cross-sectional study conducted with 210 older people. The anthropometric indicators analyzed were: body mass index, waist circumference, abdominal circumference, body adiposity index, triceps skinfold, waist-to-hip ratio, waist-to-height ratio, and conicity index. Hypertension diagnosis was self-reported. Results: The indicators of adiposity increased the probability of hypertension. Additionally, hypertensive older people of both sexes showed higher scores on adiposity indicators than non-hypertensive subjects (p < 0.05). For men, the most sensitive indicator for the outcome was conicity index (81.82%; cut-off point: 1.30) and the most specific was body mass index (69.77%; cut-off point: 25.05 kg/m2). For women, the most sensitive indicator for the outcome was the body adiposity index (86.08%; cut-off point: 31.03%), and the most specific was the abdominal circumference (82.82%; cut-off point: 98.70 cm). Conclusion: In both sexes, the indicators of adiposity were positively associated with hypertension; hypertensive participants showed higher values in the scores of the indicators. Additionally, the body adiposity index (women) and conicity index (men) demonstrated greater ability to screen for hypertension, while the abdominal circumference and body mass index demonstrated greater ability to screen for non-hypertensive women and men, respectively.

RESUMO Objetivo: Analisar a associação de indicadores antropométricos de adiposidade com a hipertensão, em pessoas idosas, de acordo com o sexo; comparar os escores dessas variáveis entre os participantes com e sem hipertensão; e identificar os indicadores com melhor capacidade preditiva à triagem do desfecho. Métodos: Estudo epidemiológico, populacional, transversal, realizado com 210 pessoas idosas. Os indicadores antropométricos analisados foram: índice de massa corporal, circunferência da cintura, circunferência abdominal, índice de adiposidade corporal, dobra cutânea tricipital, relação cintura/quadril, relação cintura/altura e índice de conicidade. O diagnóstico de hipertensão arterial foi autorreferido. Resultados: Observou-se que os indicadores de adiposidade aumentaram a probabilidade à hipertensão. Além disso, as pessoas idosas hipertensas, de ambos os sexos, apresentaram maiores escores nos indicadores de adiposidade quando comparadas às não hipertensas (p < 0,05). Para os homens, o indicador mais sensível ao desfecho foi o índice de conicidade (81,82%; ponto de corte: 1,30) e o mais específico foi o índice de massa corporal (69,77%; ponto de corte: 25,05 kg/m2). Nas mulheres, o indicador mais sensível ao desfecho foi o índice de adiposidade corporal (86,08%; ponto de corte: 31,03%) e o mais específico foi a circunferência abdominal (82,82%; ponto de corte: 98,70 cm). Conclusão: Em ambos os sexos, os indicadores de adiposidade mostraram-se positivamente associados à hipertensão; os participantes hipertensos apresentaram valores mais elevados nos escores dos indicadores. Ademais, identificou-se para os sexos, feminino e masculino, que os indicadores com melhor capacidade de rastrear a hipertensão, foram, respectivamente, o índice de adiposidade corporal e índice de conicidade. Enquanto a circunferência abdominal e o índice de massa corporal mostraram maior capacidade de rastrear, respectivamente, as mulheres e os homens não hipertensos.